HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate FDA reform bill would cost $555 mil. over six years, CBO asserts.

This article was originally published in The Rose Sheet

Executive Summary

SENATE FDA REFORM BILL IMPLEMENTATION WOULD COST $555 MIL. OVER SIX YEARS, the Congressional Budget Office asserted in its scoring of the Senate FDA reform measure (S 1477). "Most of the additional costs under the bill would result from the increased workload given to the FDA," CBO said in a July 1 analysis of the bill.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002982

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel